Neoadjuvant chemoradiotherapy in combined treatment for stage IB2-III cervical cancer patients
Vol. 60 No. 3 (2014), Articles
Vol. 60 No. 3 (2014)

Neoadjuvant chemoradiotherapy in combined treatment for stage IB2-III cervical cancer patients

Articles
https://doi.org/10.37469/0507-3758-2014-60-3-384-387
Published 15.12.2014
N.N. Petrov Research Institute of Oncology
N.N. Petrov Research Institute of Oncology
N.N. Petrov Research Institute of Oncology
N.N. Petrov Research Institute of Oncology
N.N. Petrov Research Institute of Oncology
N.N. Petrov Research Institute of Oncology
PDF (Русский)

Keywords

cervical cancer
chemoradiotherapy
cisplatin
capecitabine

How to Cite

, , , , , & . (2014). Neoadjuvant chemoradiotherapy in combined treatment for stage IB2-III cervical cancer patients. Voprosy Onkologii, 60(3), 384–387. https://doi.org/10.37469/0507-3758-2014-60-3-384-387
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Abstract

There are provided own observations on the use of cisplatin and capecitabine in schemes of combined treatment of patients with cervical cancer. Their efficiency as radiosensitizing agents is showed. There are discussed possible indications for the use of cisplatin and capecitabine in cervical cancer patients with metastatic lymph nodes.
https://doi.org/10.37469/0507-3758-2014-60-3-384-387
PDF (Русский)

References

Бохман Я.В., Вишневский А.С., Максимов С.Я. и др. Петербургская школа онкогинекологии: некоторые итоги и перспективы // Вопр. онкол. - 1997. -Т. 43. - N 1. - С. 39-46.

Бохман Я.В. Руководство по онкогинекологии. - Л., 1989. - С. 464.

Parkin D.M., Pisani P., Ferlay J. Global Cancer Statistics // Ca Cancer J. Clin. - 1999. - Vol. 49, No. 1. - P. 33-64.

All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...